N@N

DRL, NKTR, ASCA, CPO, PACR, MJN Expected To Be Up Before Next Earnings Releases

^{Published on 2011-07-27 07:11:18 - WOPRAI}
 

July 27, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and December earnings reports. DORAL FINANCIAL CORP (NYSE:DRL), NEKTAR THERAPEUTICS (NASDAQ:NKTR), AMERISTAR CASINOS INC (NASDAQ:ASCA), CORN PRODUCTS INTL INC (NYSE:CPO), PACER INTERNATIONAL INC (NASDAQ:PACR), MEAD JOHNSON NUTRITION CO (NYSE:MJN) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up Before earnings are released Friday:

     Symbol     Company                             # of Reports            Quarter     Release Date
     DRL        DORAL FINANCIAL CORP                12 Quarter              Q2          07/29/2011
     NKTR       NEKTAR THERAPEUTICS                 August Earnings         Q2          08/03/2011
     ASCA       AMERISTAR CASINOS INC               6 Quarter               Q2          08/03/2011
     CPO        CORN PRODUCTS INTL INC              July Earnings           Q2          07/28/2011
     PACR       PACER INTERNATIONAL INC             12 Quarter              Q2          07/28/2011
     MJN        MEAD JOHNSON NUTRITION CO           6 Quarter               Q2          07/28/2011

DORAL FINANCIAL CORP (NYSE:DRL) - Doral Financial Corporation, through its subsidiaries, provides a range of banking and financial services primarily in Puerto Rico and New York. It accepts deposits from the general public and institutions; obtains borrowings; originates and invests in loans, primarily residential real estate mortgage loans; invests in mortgage-backed securities, as well as in other investment securities; and offers traditional banking services. The company also provides commercial loans, such as lines of credit and term facilities to finance business operations and to provide working capital for specific purposes, such as to finance the purchase of assets, equipment, or inventory; consumer credit and personal secured loans; automobile leasing; and interim, construction, and bridge loans secured by multifamily apartment buildings and other commercial properties. In addition, it operates a federal savings bank, which gathers deposits through an Internet-based platform, originates and invests in interim loans secured by multi-family apartment buildings and commercial properties, and invests in investment securities. As of December 31, 2009, the company operated 35 branch offices in Puerto Rico. Further, Doral Financial Corporation offers property, casualty, life, and title insurance primarily to its mortgage loan customers. The company was founded in 1972 and is based in San Juan, Puerto Rico.

NEKTAR THERAPEUTICS (NASDAQ:NKTR) - Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. The companys product pipeline consists of drug candidates across various therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology. Its research and development activities involve small molecule drugs, peptides, and other potential biologic drug candidates. The companys proprietary drug candidates in clinical development comprise NKTR-118, a peripheral opioid antagonist, which has completed Phase II clinical trail for the treatment of opioid-induced constipation; BAY41-6551 that has completed Phase II clinical trail to treat gram-negative pneumonias; NKTR-102, a topoisomerase I inhibitor-polymer conjugate, which is in Phase II clinical trail for multiple cancer indications, including breast, ovarian, and colorectal; and NKTR-105 that is in Phase I clinical trail to treat solid tumors. Its preclinical products consists of NKTR-119 (Opioid/NKTR-118 combinations) for the treatment of pain; NKTR-181 (abuse deterrent, tamper-resistant opioid) to treat pain; NKTR-194 (non-scheduled opioid) for the treatment of mild to moderate pain; NKTR-171 (tricyclic antidepressant) to treat neuropathic pain; and NKTR-140 (protease inhibitor candidate) to treat HIV. The company has collaboration with Bayer Healthcare LLC to develop BAY41-6551 (NKTR-061, Amikacin Inhale), which is an inhaled solution of amikacin, an aminoglycoside antibiotic; and a license agreement with AstraZeneca AB for the development and commercialization of Oral NKTR-118 and NKTR-119. In addition, Nektar Therapeutics has various license, manufacturing, and supply agreements for its technology with biotechnology and pharmaceutical companies, such as Affymax, Amgen, Baxter, Roche, Merck, Pfizer, and UCB Pharma. The company was founded in 1990 and is headquartered in San Francisco, California.

AMERISTAR CASINOS INC (NASDAQ:ASCA) - Ameristar Casinos, Inc. operates as a gaming and entertainment company in the United States. The company develops, owns, and operates casino, and related hotel, food and beverage, entertainment, and other facilities. It primarily offers slot plays, as well as a range of table games, including blackjack, craps, roulette, and poker. The companys signature dining concepts include steakhouses, buffets, and casual dining restaurants with sports bars. As of May 6, 2011, it operated a portfolio of eight casinos in seven markets, including Ameristar Casino Resort Spa St. Charles serving greater St. Louis, Missouri; Ameristar Casino Hotel Kansas City serving the Kansas City metropolitan area; Ameristar Casino Hotel Council Bluffs serving Omaha, Nebraska and southwestern Iowa; Ameristar Casino Resort Spa Black Hawk serving the Denver metropolitan area; Ameristar Casino Hotel Vicksburg serving Jackson, Mississippi and Monroe, Louisiana; Ameristar Casino Hotel East Chicago serving the Chicagoland area; and Cactus Petes Resort Casino and The Horseshu Hotel and Casino in Jackpot, Nevada. The company was founded in 1954 and is based in Las Vegas, Nevada.

CORN PRODUCTS INTL INC (NYSE:CPO) - Corn Products International, Inc., together with its subsidiaries, manufactures and sells various food ingredients to food and industrial customers in North America, South America, Asia, and Africa. It offers food ingredients and industrial products derived from wet milling, and the processing of corn and other starch-based materials. The company provides sweetener products, including fructose corn syrups, glucose corn syrups, maltose corn syrups, dextrose, polyols, maltodextrins, and glucose and corn syrup solids; and starch products, such as industrial and food-grade starches. It also offers refined corn oil to packers of cooking oil and to producers of margarine; salad dressings; shortening; mayonnaise; and other foods. In addition, the company provides corn gluten feed that is used as protein feed for chickens, pet food, and aquaculture; and steepwater, which is used as an additive for animal feed. Corn Products International offers its products to various industries, including the food and beverage, pharmaceutical, paper products, corrugated and laminated paper, textile, and brewing industries, as well as animal feed and corn oil markets. The company was founded in 1906 and is headquartered in Westchester, Illinois.

PACER INTERNATIONAL INC (NASDAQ:PACR) - Pacer International, Inc. operates as an asset-light freight transportation and third-party logistics provider in North America. It operates in two segments, Intermodal and Logistics. The Intermodal segment provides rail brokerage, stacktrain, and local cartage services. This segment also offers ramp-to-ramp and door-to-door services. As of December 31, 2009, its equipment fleet consisted of 1,843 double-stack railcars, 25,841 containers, and 27,617 chassis. The Logistics segment provides highway brokerage, international shipping, non-vessel operating common carrier and freight forwarding services, warehousing and distribution services, and supply chain management services to end-user customers. This segment also offers airfreight forwarding services as an indirect air carrier. The company sells and supports its portfolio of services to beneficial cargo owners; steamship lines; logistics companies; truck brokers; transportation third parties, such as intermodal marketing companies and brokers; and truckload carriers primarily through its direct sales and customer service representatives. Pacer International, Inc. was founded in 1974 and is headquartered in Concord, California.

MEAD JOHNSON NUTRITION CO (NYSE:MJN) - Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, childrens nutritional products, and other nutritional products in North America, Latin America, Asia, and Europe. Its infant formula products include formulas for routine feeding; solutions formulas for mild intolerance and specialty formula products, including formulas for severe intolerance; formulas for premature and low birth weight infants; and medical nutrition products. The company also offers products for infants with milk protein allergy, gas/fussiness, lactose intolerance, anti-regurgitation, severe protein sensitivity, multiple food allergies, fat malabsorption, and premature infants, as well as soy formula. Its childrens nutrition products comprise nutritious powdered milk for picky eaters, nutritious powdered milk for picky eaters, and nutritious milk modifier. The company also offers a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers. Mead Johnson Nutrition Company markets its products under the Enfamil, Enfalac, Enfapro, Nutramigen, Pregestimil, Enfagrow, EnfaSchool, Enfakid, Sustagen KID, Lactum, ChocoMilk, Cal-C-Tose, EnfaMama, and Expecta LIPIL names. It sells its products to retail channels, including mass merchandisers, club stores, grocery stores, drug stores, and convenience stores. The company was founded in 1905 and is headquartered in Glenview, Illinois.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641